Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
All patients suffering an acute myocardial infarction will complain of chest pain.
In evaluating a patient with a suspected acute coronary syndrome, it is important to note the severity of chest pain on a scale of 1 to 10.
The response of chest pain to nitroglycerin or antacids is useful in ruling in or ruling out an acute coronary syndrome as a cause of chest pain.
A normal electrocardiogram (ECG) rules out an acute myocardial infarction.
Although Herrick attributed fatal acute MI to a thrombotically occluded coronary artery in 1912, autopsy studies in the late 1970s did not demonstrate coronary thrombosis in patients who had died of an acute MI.
Thus, coronary thrombosis was considered a consequence, rather than the underlying cause, of acute MI.
In 1980, DeWood and colleagues reported the results of coronary angiography performed early after the onset of an acute transmural MI: within 4 hours of symptom onset, 87% of infarct-obstructed arteries were completely occluded. However, 12 to 24 hours after onset, the prevalence of coronary occlusion was only 65%.
When patients with subtotal occlusion of the obstructed artery were included, the prevalence of angiographically demonstrable coronary thrombosis in the first 4 hours was 98%.
Over the past decade, further understanding of the pathology underlying acute coronary occlusion has come from autopsy studies, angiography, and intracoronary imaging: underlying culprit soft lipid plaques, thin cap fibroatheromas, bulky plaques with characteristic erosion, and/or calcified nodules have all been found to predispose to plaque rupture and coronary occlusion ( Fig. 2.1 ).
Myocardial infarction describes the process of myocardial cell death caused by ischemia or the imbalance between myocardial oxygen supply via the coronary arteries and demand.
In the United States each year, an estimated 1.1 million people experience an acute MI or die from coronary heart disease.
In 2016, it was estimated that approximately every 34 seconds one American would have a coronary event and about every 1 minute 24 seconds an individual would die from a coronary event.
According to the most recent World Health Organization report in 2015, coronary heart disease is the leading cause of death worldwide.
The early recognition and diagnosis of an acute MI are vital for the institution of therapy to limit myocardial damage, preserve cardiac function, and reduce mortality.
Patients can be grouped into two major categories of acute MI:
1. Patients with new ST segment elevation on the ECG that is diagnostic of acute ST segment elevation myocardial infarction (STEMI)
2. Patients with non–ST segment elevation myocardial infarction (NSTEMI) who have elevated cardiac biomarkers in an appropriate clinical setting, with or without ischemic ECG changes
Clinical trials have established the benefit of early reperfusion therapy in patients with STEMI and an early invasive strategy in patients with high-risk NSTEMI; thus a rapid and accurate assessment of patients with suspected acute MI is essential for optimal management.
MI is defined as myocardial necrosis caused by prolonged myocardial ischemia.
The diagnosis of an acute MI requires the rise and/or fall of cardiac biomarkers (preferably troponin) with at least one value exceeding the 99th percentile of a normal reference population (the upper reference limit) and at least one of the following:
Symptoms of ischemia
ECG changes indicative of active ischemia (new ST segment–T wave changes or new left bundle branch block [LBBB]) or infarction (new pathologic Q waves)
3. Identification of an intracoronary thrombus by angiography or autopsy
4. Imaging evidence of a new regional wall motion abnormality, or new loss of viable myocardium
The type of acute MI can be classified further depending on the etiology of the infarct ( Table 2.1 ).
Type | Description |
---|---|
1 | Spontaneous MI resulting from an atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection with resulting intraluminal thrombus |
2 | MI associated with ischemia owing to an imbalance in myocardial oxygen supply and demand, such as in coronary endothelial dysfunction, coronary artery spasm, coronary embolism, anemia, arrhythmias, hypertension, or hypotension |
3 | MI resulting in cardiac death, with symptoms suggestive of myocardial ischemia, accompanied by new ischemic electrocardiogram changes, but death occurring before blood samples could be obtained, or at a time before the appearance of cardiac biomarkers in the blood |
4a | MI associated with percutaneous coronary intervention |
4b | MI associated with stent thrombosis as documented by angiography or autopsy |
5 | MI associated with coronary artery bypass graft surgery |
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here